Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7723484 Anti-EGFR antibodies

Patent 7723484 was granted and assigned to APPLIED MOLECULAR EVOLUTION on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

APPLIED MOLECULAR EVOLUTION

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jeffry Dean Watkins0

Alain Philippe Vasserot0

Catherine Brautigam Beidler0

Date of Patent

May 25, 2010

0

Patent Application Number

120903950

Date Filed

November 6, 2006

0

Patent Citations Received

US Patent 12122844 Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies

0

US Patent 11753476 Combination therapy for cancers with BRAF mutation

US Patent 11771762 Anti-ErbB3 antibodies and uses thereof

US Patent 11976125 B cell maturation antigen binding proteins

0

US Patent 12024568 Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies

0

US Patent 12084518 Trispecific binding proteins and methods of use

0

Patent Primary Examiner

0

Patent abstract

The present invention encompasses EGFR specific monoclonal antibodies, or antigen-binding portions thereof. These antibodies, or antigen-binding portions thereof, have high affinity for EGFR, inhibit the activation of EGFR, and are useful for the treatment of EGFR mediated cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7723484 Anti-EGFR antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool